SMTL ID : 7jxh.6 (7 other biounits)

HER2 in complex with JBJ-08-178-01

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.27 Å

Oligo State

monomer

Ligands

1 x VOY: (2E)-N-[3-cyano-7-ethoxy-4-({3-methyl-4-[([1,2,4]triazolo[1,5-a]pyridin-7-yl)oxy]phenyl}amino)quinolin-6-yl]-4-(dimethylamino)but-2-enamide(Non-covalent)

VOY.1: 22 residues within 4Å: Chain A: L.28, V.36, A.53, K.55, E.72, M.76, S.85, R.86, L.87, L.98, T.100, Q.101, L.102, M.103, P.104, G.106, C.107, D.110, L.154, T.164, D.165, F.166 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.28, A:V.36, A:K.55, A:L.98, A:T.100, A:L.102, A:L.154, A:L.154, A:T.164 Hydrogen bonds: A:E.72, A:S.85, A:T.100, A:M.103, A:T.164 Salt bridges: A:D.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Son, J. et al., A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung Cancer. Cancer Res. (2022)

Release Date

2021-09-08

Peptides

Receptor tyrosine-protein kinase erbB-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
F

Receptor tyrosine-protein kinase erbB-2

Related Entries With Identical Sequence